Vericel reports record Q3 revenue $67.5M; net income $5.1M vs loss

Vericel Corp

2025-Q3 EPS reported -$0.13 revenue$183,341,000

Total revenue $67.5M (record Q3), MACI $55.7M (+25% YoY), Burn Care $11.8M (Epicel $10.4M, NexoBrid $1.5M).
Net income $5.1M ($0.10 diluted EPS) vs net loss $0.9M prior year; adjusted EBITDA $17.0M (25% rev) vs $10.0M (17%).
FY 2025 revenue guidance reaffirmed $272-276M; gross margin 74%, adjusted EBITDA margin 26%.
Operating cash flow $22.1M (record Q3); cash $185M, no debt; MACI Arthro >800 surgeons trained; MACI Ankle study on track.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.